Research: ARNOLD and COLLEAGUES,

Listed in Issue 241

Abstract

ARNOLD and COLLEAGUES, (1)Institute of Nutrition, Friedrich Schiller University, Jena, Germany conducted a randomized, double-blind, placebo-controlled, parallel trial to study the effects of a short-term pilot study intervention with an oleaginous kale extract upon age-related macular degeneration (AMD).

Background

Age-related macular degeneration (AMD) is a multifactorial degenerative disease of the retina, which accounts for slowly progressive visual impairment in the elderly. An increased dietary intake of xanthophylls is suggested to be inversely related to the risk of macular disease.

Methodology

The present study was designed as a randomized, double-blind, placebo-controlled, parallel trial examining the influence of a short-term intervention with an oleaginous extract of Brassica oleracea var. sabellica L. (kale) on plasma xanthophyll concentrations and the optical density of the macular pigment xanthophylls (MPOD). Twenty patients with non-exudative AMD were recruited for a 10-wk study period (2-wk run-in, 4-wk intervention, 4-wk washout). All participants received 50 mL of a beverage containing either an oleaginous extract of kale (kale) or refined rapeseed oil (placebo). The verum product provides 10 mg lutein and 3 mg zeaxanthin per day.

Results

The concentrations of the xanthophylls in plasma and the MPOD increased significantly in the kale group after 4 weeks of intervention. The successive washout period resulted in a significant decline of the values in plasma and macula. The values at the end of the study were still significantly higher than the initial values. Nevertheless, the improvements did not persist over 4 weeks of washout.

Conclusion

The distribution of the xanthophylls in the macula seems to be more dynamic than originally assumed.

References

Arnold C(1), Jentsch S, Dawczynski J, Böhm V.  Age-related macular degeneration: Effects of a short-term intervention with an oleaginous kale extract - a pilot study. Nutrition. 29(11-12):1412-7. doi: 10.1016/j.nut.2013.05.012. Nov-Dec 2013.

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page